MLYS vs NRG · $2.17B cap vs P/E 145, rev $17.74B
Mineralys Therapeutics, Inc. Common Stock (MLYS) versus NRG Energy Inc. (NRG) — a side-by-side from cached financials, not a winner call.
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.
NRG Energy Inc. (NRG) is a utilities - independent power producers company listed on NYSE.
MLYS does not have a complete income-statement cache yet.
Latest reported NRG revenue for 2026-06-30 was $17.74B. Net income was $631.0M. Revenue was up 72.9% from 2026-03-31 to 2026-06-30. NRG currently screens at market cap $27.88B and trailing P/E 145.2.
MLYS currently screens at market cap $2.17B. NRG currently screens at market cap $27.88B and trailing P/E 145.2.
Not investment advice. Open the MLYS and NRG stock pages for the full models.
Not investment advice.